AXC-1

........10........20........30........40........50........60........70........80........90.......100.......110.......120.......130.......140.......150.......160.......170.......180.......190.......200.......210.......220.......230.......240.......250.......260.......270.......280.......290........ MLTRRTFIASAVLAGWIPALAHARTDKKTRWTRESLAAFQQGLAQVEAASRGRLGVALLDVGSGQAAGYRADERFLMLSSFKTLSAAYVLARADRGEDQLSRRIPITDADVREYSPVTRLHVGPRGMTLAELCEATITTSDNAAVNLMHKSYGGPQALTRYLRSLGDTVTRHDRYEPELNRPHPSEPQDTTTPQAMARTLDTLLFGDALKPQSRQQLQSWLLANTTGGKRLRAGMPADWKIGEKTGTYSKVGCNDAGFAQPPGAAPIIIAAYLETTAVPMEERDRCIAEVGRLVAALG

AXC-2	...............GM....R...........D...T...A..KL.................................................................Q...................................................G......................................................................................................................................	96.64 %
AXC-3	...............GM....R...........D...T...A..KL.................................................................Q...................................................G.............................R.............................................R..........................................................	95.97 %
AXC-4	........................................................................................................................................................................................................................................................................................................M.	99.66 %
AXC-5	.........................................................................L......................................G.........................................................................................................................................................................................	99.33 %
AXC-6	.........L.....GM....R.T.........D...T...A..KL.................................................................Q...................................................G......................................................................................................................................	95.97 %
AXC-7	....................................V.....................................................................................................................................................................................................................................................................	99.66 %
AXC-8	...............GM................DN..T...A..KL.................................................................Q...................................................G.............................R........................................................................................................	96.31 %

Last updated: April 06, 2026.

If you use BLDB please cite: Naas, T.; Oueslati, S.; Bonnin, R. A.; Dabos, M. L.; Zavala, A.; Dortet, L.; Retailleau, P.; Iorga, B. I., Beta-Lactamase DataBase (BLDB) – Structure and Function. J. Enzyme Inhib. Med. Chem. 2017, 32, 917-919.

The development of the BLDB database was funded in part by the JPIAMR transnational project DesInMBL, the Région Ile-de-France (DIM Malinf) and the Laboratory of Excellence in Research on Medication and Innovative Therapeutics (LERMIT).

Contact: contact@bldb.eu

Live statistics (since March 29th, 2025)